Corona Remedies IPO GMP, Open Date, Price Band, Issue Size

Corona Remedies IPO open date is December 8, 2025, and the closing date is December 10, 2025. This new IPO is a book-built issue of 61,71,101 equity shares aggregating up to Rs 655.37 crore. This upcoming IPO is being offered entirely as an offer for sale, and there is no fresh issue component in the IPO.

Corona Remedies IPO price band is Rs 1,008 to Rs 1,062 per share. As of December 2, 2025, the Corona Remedies IPO GMP Live quotation is at Rs 161 (+15.16%) per share. Live IPO Grey Market Premium details will be available online.

Corona Remedies IPO allotment status will be available on December 11, 2025. Corona Remedies IPO lot size is 14 shares. The minimum investment for retail investors for 1 lot is Rs 14,868. The registrar for the Corona Remedies IPO is Bigshare Services Pvt Ltd. Corona Remedies IPO listing date is December 15, 2025.

Also Read | Wakefit Innovations IPO GMP, Open Date, Price Band, Issue Size

Corona Remedies IPO GMP

Corona Remedies IPO GMP is Rs 161 (+15.16%) per share as on December 3, 2025. The IPO GMP today indicates a positive premium in the grey market ahead of the subscription opening. Investors can check the latest IPO Grey Market Premium online from the first day of the subscription window. If the subscription is oversubscribed, then Corona Remedies IPO GMP may further increase.

Corona Remedies IPO Open Date, Close Date

Corona Remedies IPO open date is December 8, 2025, and the IPO close date is December 10, 2025. The initiation of the refund date is December 12, 2025, and the credit of shares will be on December 12, 2025.

Corona Remedies IPO Price Band

Corona Remedies IPO price band is Rs 1,008 to Rs 1,062 per share. The minimum amount of investment for the retail category is Rs 14,868, and for small HNI, the minimum investment is Rs 2,08,152. The minimum investment for the Big HNI is Rs 10,11,024.

Corona Remedies IPO Issue Size

Corona Remedies IPO is a book-built issue of 61,71,101 equity shares aggregating up to Rs 655.37 crore. The entire issue is being offered as an offer for sale, and there is no fresh issue component in this IPO.

Corona Remedies IPO Allotment Status

Corona Remedies IPO allotment status will be available on December 11, 2025. The listing will be on the BSE and NSE platforms. The registrar for this IPO is Bigshare Services Pvt Ltd. Investors can check their allotment status after the subscription ends by visiting the registrar’s website.

Corona Remedies IPO Listing Date

Corona Remedies IPO listing date is December 15, 2025. The listing will be on the BSE and NSE platforms. Retail investors can sell their shares after 10 AM on the listing day.

Corona Remedies IPO: Listing Date, Lot Size, Price Band

Corona Remedies Limited: About the Company

Corona Remedies Limited, incorporated in 2004, is a pharmaceutical company engaged in the development, manufacturing, and marketing of branded formulations across various therapeutic segments. The company focuses on chronic and acute therapies including gastroenterology, cardiology, dermatology, orthopedics, gynecology, respiratory care, and general medicine.

Corona Remedies operates multiple manufacturing facilities and has built a strong distribution network across India. The company offers more than 700 products and has established a strong presence in both acute and chronic care markets. With a wide portfolio of scientifically driven formulations, Corona Remedies has built valuable relationships with healthcare professionals and medical institutions across India.

The company’s commitment to quality manufacturing and research-driven product expansion has helped it become a fast-growing pharmaceutical player in India.

Corona Remedies IPO Objectives

Corona Remedies IPO is entirely an offer for sale. The company will not receive any proceeds from the IPO. The funds received from the IPO will directly go to the selling shareholders.

Corona Remedies IPO: Key Dates, Allotment, Listing Date

Corona Remedies Limited: Financials (Amount in Cr)

Corona Remedies IPO Lot Size Details

Corona Remedies IPO lot size is 14 shares.
The minimum investment for the retail category is Rs 14,868, and for small HNI, the minimum investment is Rs 2,08,152.

Corona Remedies IPO Promoter Holdings

The promoters of Corona Remedies Limited are Dr. Kirtikumar Laxmidas Mehta, Niravkumar Kirtikumar Mehta and Ankur Kirtikumar Mehta. The promoter shareholding before the IPO was 72.50%; after the IPO, the promoter shareholding will be going to decline.

Corona Remedies IPO Registrar

Corona Remedies IPO registrar is Bigshare Services Pvt Ltd. Investors can check their allotment status via the registrar’s website using PAN or application ID.

How to Apply to the Corona Remedies IPO

Investors can apply to the Corona Remedies IPO through the Bigul trading app by clicking here.
They can also check the details of other upcoming IPOs available on Bigul.

Corona Remedies IPO FAQ

1. What are the details of the Corona Remedies IPO?

Corona Remedies IPO is a book-built issue of 61,71,101 equity shares aggregating up to Rs 655.37 crore offered entirely as an offer for sale.

2. When will the Corona Remedies IPO open and close?

Corona Remedies IPO open date is December 8, 2025, and the close date is December 10, 2025. Refunds begin on December 12, 2025, and shares are credited on the same day.

3. What is Corona Remedies IPO GMP?

The Corona Remedies IPO GMP is Rs 161 (+15.16%) per share as on December 2, 2025.

4. What is the allotment date for the Corona Remedies IPO?

The allotment for the Corona Remedies IPO will be declared on December 11, 2025.

5. Who is the registrar and lead managers for the Corona Remedies IPO?

Aequs IPO registrar is Bigshare Services Pvt Ltd, and the lead managers are JM Financial Ltd, Kotak Mahindra Capital Co. Ltd, and IIFL Capital Services Ltd.

Also Read | Meesho IPO GMP, Open Date, Price Band, Issue Size